Heart Test Laboratories to effect 1-for-100 reverse stock split on May 17, 2024

HeartSciences Inc.

Reverse stock split of common stock and warrants at 1-for-100 ratio, effective at market open on May 17, 2024.
Post-split CUSIP for common stock is 42254E302; trading symbols HSCS and HSCSW unchanged.
Warrant exercise price adjusted proportionally to $425.00 per share; fractional shares rounded up.
Adjustments to outstanding warrants ensure equitable conversion for holders.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

HeartSciences Inc.: Certificate of Amendment to Amended and Restated Certificate of Formation to effect a 1-for-100 reverse stock split of Common Stock and Warrants (effective 2024-05-06).

Change: charter amendment
Effective: 2024-05-06

Exact text from the filing

the Company filed a Certificate of Amendment to its Amended and Restated Certificate of Formation (the “Certificate of Amendment”) with the Secretary of State of Texas to, among other things, effect on the corporate level a one-for-one hundred reverse stock split (the “Reverse Stock Split”) of the Company’s shares of common stock, $0.001 par value per share (the “Common Stock”), and also to effect a one-for-one hundred Reverse Stock Split of the Company’s warrants (the “Warrants”).

View on SEC.gov

Browse all governance changes →

HeartSciences Inc. filing history →

Source: SEC EDGAR

accession 0001213900-24-043196

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.